Psilocybin rescues sociability deficits in an animal model of autism
Mollinedo-Gajate, I.; Song, C.; Sintes-Rodriguez, M.; Whelan, T.; Soula, A.; Selimbeyoglu, A.; Hurley, S.; Knöpfel, T.
Show abstract
Autism spectrum disorder (ASD) is characterized by core deficits in social interaction. The classic serotonergic psychedelic psilocybin has been suggested as a therapeutic agent that may ameliorate in the core symptomology of ASD. We found that the acute response to psilocybin was attenuated in the prenatal valproic acid exposure mouse model of ASD, and importantly, psilocybin rescued the social behavioural abnormalities present in these ASD model mice.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (+/-)-DOI) on cognitive flexibility 95%
- Serotonin sensing by microglia conditions the proper development of neuronal circuits and of social and adaptive skills 95%
- Cell-type specific transcriptional adaptations of nucleus accumbens interneurons to amphetamine 93%
Similar papers in this journal
- Transcriptomic signatures of sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypes 95%
- Identification of a stress-sensitive endogenous opioid-containing neuronal population in the paranigral ventral tegmental area. 94%
- Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autism 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.